Our Accomplishments
The MpBC Global Alliance, Inc. is a nonprofit organization founded and administered by volunteers and supported by noted researchers and oncologists.
The Mission of this alliance is to help consolidate knowledge and research into Metaplastic Carcinoma of the Breast.
Below is a timeline of milestones since June 2016 when 3 diagnosed women joined efforts to support the advancement of research into this rare and complicated breast cancer.
May 2018
- Introduced our Member Poll Page
November 2017
- Met with Drs. Moulder and Janku at MD Anderson in Houston to further our collaboration
- Set up a system to expedite Stage 4 Patients with appointments to Dr. Moulder at MDA
- Affiliated with and supported by Smart Patients
- Affiliated with and supported by MBC Project-Broad Institute Harvard
- Affiliated with and supported by Metavivor
- Designed Thank you/Appreciation Plaques for business supporters
September 2017
- Website Verified and Secured with Braintree
- Set up and secured website shop
- Startup of Initial Tervis sales
August 2017
- Received Non-Profit Status from IRS
- Facilitated listing charity on GuideStar/IRS Database of Charities

June 2017
- Purchased a second domain: metaplasticbreastcancer.org
May 2017
- MpBC Global Alliance Inc. Partnered with the Women’s Only Metaplastic Breast Cancer Facebook Group
- Started to grow the Publication Section on website
January 2017
- Redesigned and updated website
September 2016
- Listed and documented as a support/advocacy group through NIH-GARD (National Center for Genetic and Rare Diseases)
- Opened up PayPal account for T-shirt sales
- Designed and began handing out Metaplastic Breast Cancer Information Cards
- Registered and documented on The Global Genes Rare Foundation List
June 2016
- Opened up Facebook online community MpBC Global Alliance
- Began developing the website domain mpbcglobalalliance.org
- Started documenting diagnosed members on our global map located on website
- Began introducing MpBC Global Alliance to research oncologist’s and experts in the field of rare breast cancers